PRIMA-1

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NamePRIMA-1
Drug Alias Namep53 reactivation and induction of massive apoptosis
ClassificationOther
Mechanisms of ActionApoptosis stimulantsTumor protein p53 stimulants
TargetsTumor protein p53
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenRussian Federation
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKarolinska InstitutetRussian Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRussian Academy Of SciencesKarolinska Institutet
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A